2022
DOI: 10.1021/acsomega.1c06951
|View full text |Cite
|
Sign up to set email alerts
|

Antiproliferative Activity of Some Newly Synthesized Substituted Nicotinamides Candidates Using Pyridine-2(1H) thione Derivatives as Synthon

Abstract: Some new pyridinethione and thienopyridine derivatives have been synthesized and evaluated for their antiproliferative activity using the MTT assay. Nicotinamide derivatives 3 have been synthesized and used for the preparation of new condensed thieno [2,3- b ]pyridines by their reactions with active halo compounds. Finally the synthesized thienopyridine underwent ring closure whenever possible through boiling in a solution of sodium ethoxide. The antiproliferative … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 36 publications
(54 reference statements)
0
2
0
Order By: Relevance
“…Thieno­[2,3- b ]­pyridine derivatives occupy a unique position and have received considerable attention due to their diverse pharmacological activities, which include anticancer, , antiviral, , anti-inflammatory, , antimicrobial, , antidiabetic, , and osteogenic antiproliferative activity. Furthermore, they can be used as adenosine A1 receptor ligands for the potential treatment of epilepsy and as antiplatelet drugs .…”
Section: Introductionmentioning
confidence: 99%
“…Thieno­[2,3- b ]­pyridine derivatives occupy a unique position and have received considerable attention due to their diverse pharmacological activities, which include anticancer, , antiviral, , anti-inflammatory, , antimicrobial, , antidiabetic, , and osteogenic antiproliferative activity. Furthermore, they can be used as adenosine A1 receptor ligands for the potential treatment of epilepsy and as antiplatelet drugs .…”
Section: Introductionmentioning
confidence: 99%
“…Based on these findings, and as a continuation of our earlier efforts in the production of bioactive heterocyclic compounds (Alhasani et al, 2022;Almehmadi et al, 2021;Alsaedi, Almehmadi, et al, 2022;Alsaedi, Farghaly, et al, 2022;Althagafi et al, 2019;Elnaggar et al, 2022;Farghaly et al, 2022;Janssen & Jageneau, 1957;Katowah et al, 2022;Mahmouda et al, 2021;Shaaban et al, 2022), we have synthesized new series of tricyclic/tetracyclic benzosuberane carrying morpholine moiety with the aim of designing effective antibreast cancer agents that can inhibit the CDK2 enzyme. Here, the crucial binding interactions with the ATP binding site of CDK2 were preserved (Figure 3) by retaining the planar benzosuberane scaffold that is linked to groups capable of binding to the hinge region key residues via hydrogen bonds and linked to phenyl group that was expected to occupy the hydrophobic pocket of the enzyme.…”
mentioning
confidence: 99%